ask="9.76"
ask_size="100"
average_daily_volume="59148"
bid="5.86"
bid_size="100"
book_value="0.00"
change="+0.10"
change_from_200_day_moving_average="0.83"
change_from_50_day_moving_average="0.11"
change_from_52_week_high="-3.60"
change_From_52_week_low="2.45"
change_in_percent="+2.00%"
close="5.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.27"
ebitda="0.00"
eps_estimate_current_year="-5.06"
eps_estimate_next_quarter="-0.70"
eps_estimate_next_year="-2.28"
ex_dividend_date="N/A"
float_shares="N/A"
high="5.24"
high_52_weeks="8.70"
last_trade_date="3/16/2017"
last_trade_price="5.10"
last_trade_size="100"
last_trade_time="3:59pm"
low="4.99"
low_52_weeks="2.65"
market_capitalization="N/A"
moving_average_200_day="4.27"
moving_average_50_day="4.99"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.99"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+19.53%"
percent_change_from_50_day_moving_average="+2.26%"
percent_change_from_52_week_high="-41.38%"
percent_change_from_52_week_low="+92.45%"
previous_close="5.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.00"
stock_exchange="NCM"
symbol="CLBS"
volume="94102"
weeks_range_52="2.65 - 8.70"
